About Sapheon
Sapheon is a Healthcare company based in Morrisville (United States) founded in 2008, and was acquired by Covidien in August 2014. Closure system for treatment of venous reflux disease. Sapheon has raised $57.52 million across 12 funding rounds from investors including Covidien. The company has 20 employees. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation; 3 of its 3 listed competitors have raised funding.
Company details
Sapheon develops medical supplies and devices for the treatment of vascular diseases. The company focuses on developing VenaSeal Sapheon Closure System for the treatment of venous reflux disease.
- Headquarters Morrisville, United States
- Employees 20
- Stage Acquired
- SectorsHealthcare
- Website sapheon.net
- Social LinkedIn X
- Acquired by Covidien (Aug 2014)
Funding Insights of Sapheon
Sapheon has successfully raised a total of $57.52M across 12 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.6 million completed in November 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $57.52M
- Total Rounds 12
- Last Round Debt – Conventional — $3.6M
- First Round $50,000
(Oct 2008)
Latest 10 of 12 funding rounds of Sapheon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2013 | $3.6M | Debt – Conventional | – | – | – |
| Oct 2013 | $3.6M | Debt – Conventional | – | – | – |
| Oct 2013 | $10M | Debt – Conventional | – | – | – |
| Sep 2013 | $19.8M | Series B | – | – | – |
| Sep 2013 | $19.8M | Series B | – | – | – |
| Aug 2012 | $3.1M | Series B | – | – | – |
| Aug 2012 | $8.6M | Series B | – | – | – |
| Mar 2012 | $1.32M | Series A | – | – | – |
| Mar 2011 | $2.4M | Series A | – | – | – |
| Mar 2011 | $2.4M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Sapheon
Sapheon has secured backing from 1 investor. Prominent investors backing the company include Covidien.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical devices for minimally invasive therapies are provided globally. | 2007 | covidien.com | Dublin, Ireland |
Investor details for Sapheon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Sapheon
4 dated milestones of Sapheon across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Sapheon is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Debt – Conventional, of $3.6M.
- Exit Acquired by Covidien.
Competitors of Sapheon
Sapheon has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Aziyo Biologics and EKOS Corporation.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| ekoscorp.com | 1995 | Bothell, United States | $58.8M | Ultrasound thrombolytic devices for pulmonary embolism treatment are developed. |
Detailed competitors of Sapheon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Sapheon (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sapheon
Complete news archive for Sapheon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sapheon
Sapheon was founded in 2008.
Sapheon is headquartered in Morrisville, United States.
Sapheon is a funded company, having raised a total of $57.52M across 12 funding rounds to date. The company's 1st funding round was a Series A of $2.4M, raised on Oct 2008.
Sapheon has 20 employees.
Sapheon develops medical supplies and devices for the treatment of vascular diseases. The company focuses on developing VenaSeal Sapheon Closure System for the treatment of venous reflux disease.
Sapheon's top competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation.
Sapheon has 1 investor. Key investors include Covidien.
Yes. Sapheon was acquired by Covidien in August 2014.